Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SavariaFRA:S97 -1.74%94 3-Year EBITDA Growth Rate is 7.80% as of Jun. 2026, which is 42% below its 10-year median of 13.40. GuruFocus rates FRA:S97 with a GF Score™ of 94/100 and a GF Value™ of €13.15. The stock has 3 warning signs investors should review. Among 2,600 Industrial Products companies, Savaria ranks better than 56.77% on this metric.
During the past 12 months, Savaria's average EBITDA Per Share Growth Rate was 24.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 7.80% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 14.30% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 17.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Savaria was 32.70% per year. The lowest was -5.80% per year. And the median was 13.40% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Savaria 3-Year EBITDA Growth Rate Related Terms
FRA:S97 vs GEV, ETN, PH: 3-Year EBITDA Growth Rate Comparison
For the Specialty Industrial Machinery subindustry, Savaria's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Savaria 3-Year EBITDA Growth Rate vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Savaria's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Savaria's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 7.80% mean?
Savaria (FRA:S97) has a 3-Year EBITDA Growth Rate of 7.80% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Savaria and its competitors. This is 42% below median its historical median of 13.40. According to the industry distribution chart, Savaria ranks #1124 out of 2600 companies in the Industrial Products industry, placing it in the top 43.2%.
Is Savaria's 3-Year EBITDA Growth Rate too high?
Savaria's current 3-Year EBITDA Growth Rate of 7.80% is 42% below median its 10-year median of 13.40. The Industrial Products industry median 3-Year EBITDA Growth Rate is 4.40. Savaria's value of 7.80% is 77.3% above this industry median. Based on the distribution chart, Savaria ranks #1124 out of 2600 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Savaria has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Savaria's 3-Year EBITDA Growth Rate compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Savaria ranks #1124 out of 2600 companies for 3-Year EBITDA Growth Rate. This puts Savaria in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 4.40. Savaria's value of 7.80% is 77.3% above this benchmark. While the company's 10-year median is 13.40 vs. the industry median of 4.40, Savaria has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Industrial Products company?
The median 3-Year EBITDA Growth Rate among Industrial Products companies is 4.40, based on 2,600 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Savaria's current 3-Year EBITDA Growth Rate of 7.80% is 77.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Savaria and its competitors. For the Industrial Products industry, the median 3-Year EBITDA Growth Rate is 4.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Savaria's current 3-Year EBITDA Growth Rate is 7.80%, which is 42% below median its own 10-year median of 13.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savaria stock overvalued right now?
Savaria (FRA:S97) has a current 3-Year EBITDA Growth Rate of 7.80%. The stock's GF Value™ is €13.15, compared to a current price of €16.90 — trading 28.5% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 7.80%, which is 42% below median its 10-year median of 13.40 and 77.3% above the Industrial Products industry median of 4.40. Savaria's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Savaria (FRA:S97), the current 3-Year EBITDA Growth Rate is 7.80% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Savaria (FRA:S97) Overvalued in 2026?
Based on GuruFocus' analysis, Savaria stock appears to be overvalued.
The current stock price of €16.90 is trading 28.5% above its estimated GF Value™ of €13.15.
Key valuation signals for FRA:S97:
3-Year EBITDA Growth Rate: 7.80% (42% below median its 10-year median of 13.40)
GF Value™: €13.15 vs. price of €16.90 (28.5% above fair value)
Industry Position: 77.3% above the Industrial Products median (#1124 of 2600)
No single metric tells the full story. See the FRA:S97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility and Patient Care. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Patient Care segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market. The company derives maximum revenue from Accessibility segment.
94GF Score
Get the complete analysis for FRA:S97
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S97 has been successfully added to your 
